The table below shows AbbVie Inc.'s cash flow statement by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
Line item
Q1 2026
Q1 2025
Q1 2024
Q1 2023
Q1 2022
Q1 2021
Operating cash flow
$3.83B
$1.64B
$4.04B
$4.19B
$4.91B
$4.88B
Capital expenditure
$265.00M
$235.00M
$193.00M
$175.00M
$162.00M
$188.00M
Investing cash flow
-$574.00M
-$735.00M
-$9.59B
-$499.00M
-$1.59B
-$342.00M
Dividends paid
$3.09B
$2.92B
$2.77B
$2.66B
ABBV operating cash flow (10-K history)
AbbVie Inc. reported operating cash flow of $19.03B for fiscal year 2025. That is up 1.2% from $18.81B in fiscal 2024. Over the 9 fiscal years shown, operating cash flow grew from $9.96B (FY 2017) to $19.03B. Figures come from the company's audited annual reports as filed with the SEC.
